ENGN enGene Holdings Inc.

P/E --
Forward P/E --
Price/Sales --
Beta -0.285
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 enGene Holdings is trading 5.5% up in pre-market as biotech ETF XBI rises 3.64%

enGene Holdings is trading at $1.72, up 5.52%, alongside biotech-sector strength; XBI was up 3.64% pre-market. - No new company-specific announcement...

🟢 enGene Holdings is trading 5% up today alongside a 2.10% XBI gain

enGene Holdings is trading at $1.66, up 5.06%, alongside a biotech-sector rally; no direct company-specific catalyst was identified. - No fresh...

🟢 enGene Holdings is trading 5.74% up in after-hours trading

enGene Holdings is trading 5.74% higher at $1.67 after-hours, with no clear company-specific catalyst identified. - It closed at $1.58 on October 19; its...

🔴 enGene Holdings is trading 5.5% down in after-hours trading with no clear catalyst identified

enGene Holdings is trading 5.5% lower at $1.62 after hours, with no clear company-specific catalyst identified. - It closed at $1.71 on October 15, then...

🟢 enGene Holdings is trading 6% up today amid biotech-sector gains

enGene Holdings is trading at $1.66, up 6.09%, with biotech-sector strength the clearest available context. - XBI is up 2.20% during regular trading. - No...

🟢 enGene Holdings is trading 5% up in pre-market with no clear catalyst identified

enGene Holdings is trading at $1.64, up 5.13% in pre-market, with no clear company-specific news explaining the rise. - enGene announced a KOL webinar for...